Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study

Domenico Lio, Sergio Salerno, Vincenzo Serretta, Piazza, Vincenzo Serretta, Bruna Piazza

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubicin instillation. © 1993 Springer-Verlag.
Original languageEnglish
Pages (from-to)353-357
Number of pages5
JournalUrological Research
Volume21
Publication statusPublished - 1993

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint Dive into the research topics of 'Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot study'. Together they form a unique fingerprint.

Cite this